Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Janus Henderson Group PLC

Janus Henderson Group PLC boosted its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 3.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,364 shares of the company’s stock after acquiring an additional 1,743 shares during the period. Janus Henderson Group PLC owned 0.31% of Addus HomeCare worth $7,365,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. raised its holdings in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares in the last quarter. Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the second quarter worth $31,000. Farther Finance Advisors LLC raised its holdings in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the period. Innealta Capital LLC acquired a new stake in shares of Addus HomeCare during the second quarter worth $44,000. Finally, Sandia Investment Management LP acquired a new stake in shares of Addus HomeCare during the second quarter worth $58,000. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Stock Down 0.0 %

Shares of ADUS opened at $120.72 on Tuesday. The firm has a 50-day moving average price of $126.01 and a 200 day moving average price of $124.24. The firm has a market capitalization of $2.19 billion, a PE ratio of 27.62, a P/E/G ratio of 2.11 and a beta of 1.02. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 EPS. On average, equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on ADUS shares. Stephens increased their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Oppenheimer increased their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Tuesday, December 3rd. KeyCorp assumed coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.